BIOACCELERATE ANNOUNCES NAME CHANGE, NEW STRATEGY AND PLANNED DISTRIBUTION TO SHAREHOLDERS

Bioaccelerate Holdings, Inc today announced that it is has received majority shareholder approval to change its name to Gardant Pharmaceuticals, Inc. The Company also announced that it has adopted a new business strategy intended to increase overall shareholder value.
PrimeZone